Vimarsana
Biggest News Aggregation in the World

Page 2 - Fda Approves News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fda Approves. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fda Approves Today - Breaking & Trending Today

Zurzuvae | FDA approves first postpartum depression pill in the US - Vimarsana News

Zurzuvae | FDA approves first postpartum depression pill in the US

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

Source: abc13.com
FDA Approves OTC Naloxone Nasal Spray RiVive For Opioid Overdose - Vimarsana News

FDA Approves OTC Naloxone Nasal Spray RiVive For Opioid Overdose

The U.S. Food and Drug Administration approved Harm Reduction Therapeutics' RiVive, 3 milligram naloxone hydrochloride nasal spray for over-the-counter or OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose.

RSV antibody shot nirsevimab gets FDA approval to protect infants from virus - Vimarsana News

RSV antibody shot nirsevimab gets FDA approval to protect infants from virus

Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.

Source: abc7.com
RSV antibody shot nirsevimab gets FDA approval to protect infants from virus - Vimarsana News

RSV antibody shot nirsevimab gets FDA approval to protect infants from virus

Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.

Source: abc11.com
FDA Approves Pfizer's COVID-19 Pill Paxlovid - Vimarsana News

FDA Approves Pfizer's COVID-19 Pill Paxlovid

The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults.